We are live on ! Find out more
BTTX

Better Therapeutics, Inc. Common Stock
BTTX

Delisted

BTTX was delisted on the 15th of March, 2024.

Back to rankings

1 hedge funds and large institutions have $37 invested in Better Therapeutics, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% less funds holding

Funds holding: 3 → 1 (-2)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

97% less capital invested

Capital invested by funds: $1.45K → $37 (-$1.42K)

Holders
1
Holders Change
-2
Holders Change %
-66.67%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AA
Ancora Advisors
Ohio
+$37

Top Sellers

Rank Fund Capital Flow
1
CIAS
Capital Investment Advisory Services
North Carolina
-$994
2
XT
XTX Topco
Cayman Islands
-$457
3
APC
Aspire Private Capital
North Carolina
-$3

BTTX Hedge Fund Activity: Q2 2024 in Review

1 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Better Therapeutics, Inc. Common Stock (BTTX) for Q2 2024, worth a combined $37 — down 97% from $1.45K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of BTTX and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was Ancora Advisors, opening a new position worth an estimated $37. The largest seller was Capital Investment Advisory Services, exiting entirely with an estimated $994 sold.

  • 1 institutional investor held Better Therapeutics, Inc. Common Stock (BTTX) as of Q2 2024, down from 3 in Q1 2024.
  • Funds reported $37 of Better Therapeutics, Inc. Common Stock stock for Q2 2024, down 97% quarter-over-quarter.
  • 1 fund opened new Better Therapeutics, Inc. Common Stock positions in Q2 2024 and 3 closed out, a net change of -2 holders.
  • The largest Better Therapeutics, Inc. Common Stock buyer in Q2 2024 was Ancora Advisors, an estimated $37 added.
  • The largest Better Therapeutics, Inc. Common Stock seller in Q2 2024 was Capital Investment Advisory Services, an estimated $994 sold.

Based on aggregated 13F filings for Q2 2024.